ロード中...
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells
Dihydroartemisinin (DHA), an antimalarial drug, has previously unrecognized anticancer activity, and is in clinical trials as a new anticancer agent for skin, lung, colon and breast cancer treatment. However, the anticancer mechanism is not well understood. Here, we show that DHA inhibited prolifera...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3871936/ https://ncbi.nlm.nih.gov/pubmed/23929438 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/carcin/bgt277 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|